If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTILS.L Regulatory News (TILS)

  • There is currently no data for TILS

Share Finance Facility

15 Sep 2005 08:00

ReGen Therapeutics PLC15 September 2005 ReGen Therapeutics Plc Date 15 September 2005 Committed Share Finance Facility ReGen Therapeutics Plc ("ReGen" or the "Company") announces that on 14thSeptember 2005 it entered into an agreement with the Headstart Group of funds ("Headstart") under which Headstart will make available to the Company acommitted share finance facility of up to Β£2,000,000 (the "Headstart Facility"). Pursuant to the terms of the Headstart Facility, Headstart has agreed, whencalled upon by the Company, to subscribe for, or purchase, new ordinary sharesin the capital of the Company ("Ordinary Shares") to the value of up to, inaggregate, Β£2,000,000. The Headstart Facility is available at any time up to 3years from the date a Committed Share Finance Facility Agreement is entered intoby the Company and Headstart and can be drawn down by the Company in incrementsof up to Β£50,000. The subscription price for an Ordinary Share shall be equalto 95% of the lowest closing bid price of an Ordinary Share in the fifteentrading days following the date on which the Company notifies Headstart that itwishes to make a draw down under the Headstart Facility. In consideration for Headstart making available the Headstart Facility, theCompany has agreed to pay Headstart a one-off underwriting commission of Β£60,000payable by the issue of Ordinary Shares (on the basis of an agreed value perOrdinary Share of 1.35p, being the closing bid price on Wednesday 7th September2005). Β£30,000 of the underwriting commission was payable upon entering into theHeadstart Facility and the remaining Β£30,000 is payable on the first anniversarythereafter. Accordingly, application has been made for 2,222,222 OrdinaryShares to be admitted to trading on the AIM market. It is expected thatadmission to listing will become effective and that dealings in these shareswill commence on Tuesday 20th September 2005. In addition, the Company hasagreed, subject to shareholder approval, to issue warrants granting Headstartthe right to subscribe for up to 4,000,000 Ordinary Shares at a subscriptionprice of 1.65p per share, being a price equal to 110% of the closing bid priceof the Company's shares on 13th September 2005. Such warrants will beexercisable at any time on or before 14th September 2008. As the issue of theWarrants is subject to shareholder approval, ReGen will shortly send toshareholders a circular containing a notice convening an extraordinary generalmeeting of the Company (the "Circular") for 10.00 a.m. on 10 October 2005 (the "EGM") containing resolutions to, inter alia, approve the issue of the Warrants. Copies of the Circular will be available, for collection only, free of charge tothe public, from the Company, Suite 406, Langham House, 29-30 Margaret Street,London W1W 8SA during normal office hours on any day (Saturdays, Sundaysexcepted) from 19 September 2005 until 14 October 2005. - For further information, please contact:Andrew MarshallMarshall Robinson RoeTel No 020 7960 6007 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
11th Oct 20071:34 pmRNSHolding(s) in Company
1st Oct 20077:01 amRNSProduct Launch
20th Sep 20077:00 amRNSInterim Results
19th Sep 20077:02 amRNSChange of Adviser
23rd Aug 20077:00 amRNSResearch Update
21st Aug 200711:59 amRNSHolding(s) in Company
10th Aug 200711:52 amRNSHolding(s) in Company
1st Aug 20077:01 amRNSWebsite Compliance
16th Jul 20077:01 amRNSRe Contract
29th Jun 20077:02 amRNSTotal Voting Rights
21st Jun 200712:18 pmRNSHolding(s) in Company
20th Jun 20071:29 pmRNSHolding(s) in Company
14th Jun 20071:34 pmRNSIssue of Equity
11th Jun 20077:01 amRNSResearch Update
15th May 20071:00 pmRNSAGM Statement
15th May 200712:00 pmRNSAGM Statement
24th Apr 20074:44 pmRNSNotice of AGM
19th Apr 200710:01 amRNSHolding(s) in Company
19th Apr 200710:00 amRNSHolding(s) in Company
19th Mar 20077:03 amRNSFinal Results
28th Feb 20076:17 pmRNSTotal Voting Rights
14th Feb 20074:37 pmRNSHolding(s) in Company
14th Feb 20074:34 pmRNSHolding(s) in Company
14th Feb 20074:33 pmRNSHolding(s) in Company
12th Feb 20074:34 pmRNSHolding(s) in Company
12th Feb 20074:34 pmRNSHolding(s) in Company
12th Feb 20074:30 pmRNSHolding(s) in Company
6th Feb 20077:01 amRNSIssue of Equity
5th Feb 20077:01 amRNSResearch Update
2nd Feb 20071:33 pmRNSHolding(s) in Company
15th Jan 20074:39 pmRNSHolding(s) in Company
20th Dec 200611:19 amRNSTotal Voting Rights
15th Dec 20064:39 pmRNSHolding(s) in Company
12th Dec 20066:33 pmRNSDirector/PDMR Shareholding
11th Dec 20061:14 pmRNS5th Annual City Presentation
7th Dec 200611:00 amRNSResearch Update
5th Dec 20066:18 pmRNSDirector/PDMR Shareholding
26th Sep 200611:59 amRNSEGM Statement
26th Sep 20068:00 amRNSInterim Results
1st Sep 20063:19 pmRNSNotice of EGM
25th Aug 20067:00 amRNSResearch Update
17th Aug 200610:35 amRNSChange of Adviser
21st Jul 20067:00 amRNSIssue of Equity
14th Jul 20065:38 pmRNSTrading Statement
13th Jul 20067:01 amRNSLicence Agreement
4th Jul 200610:19 amRNSResponse to press comment
13th Jun 200611:57 amRNSAGM Statement
22nd May 200611:11 amRNSResearch Update
19th May 20067:00 amRNSNotice of AGM
12th May 20067:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.